Floatz logo

FENTANYL

Refractory T Acute Lymphoblastic Leukemia

City of Hope Medical CenterSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Refractory T Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
PEGASPARGASE
M.D. Anderson Cancer Center
Phase 1/2CCC
Calcium folinate pentahydrate
M.D. Anderson Cancer Center
Phase 1/2CCC
(+)-VINCRISTINE
M.D. Anderson Cancer Center
Phase 1/2CCC
Cpx-351
Children's Oncology Group
Phase 1/2CCC
PREDNISONE TABLETS
M.D. Anderson Cancer Center
Phase 1/2CCC

View all 27 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →